end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableAndOtherAccruedLiabilitiesCurrent,AccountsPayableCurrent,AccruedBonusesCurrent,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,AdditionalPaidInCapitalCommonStock,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,AllocatedShareBasedCompensationExpense,Assets,AssetsCurrent,CapitalExpendituresIncurredButNotYetPaid,CashAndCashEquivalentsAtCarryingValue,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,CommonStockCapitalSharesReservedForFutureIssuance,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,ConversionOfStockAmountConverted1,DeferredFinanceCostsNet,DeferredRentCreditNoncurrent,DepreciationDepletionAndAmortization,EarningsPerShareBasicAndDiluted,FairValueAssetsLevel1ToLevel2TransfersAmount,FairValueAssetsLevel2ToLevel1TransfersAmount,GeneralAndAdministrativeExpense,IncreaseDecreaseInAccountsPayable,IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities,IncreaseDecreaseInDeferredLiabilities,IncreaseDecreaseInOtherNoncurrentLiabilities,IncreaseDecreaseInOtherOperatingAssets,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,LesseeOperatingLeaseLiabilityPaymentsDue,LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths,LesseeOperatingLeaseLiabilityPaymentsDueYearFour,LesseeOperatingLeaseLiabilityPaymentsDueYearThree,LesseeOperatingLeaseLiabilityPaymentsDueYearTwo,LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NonoperatingIncomeExpense,OperatingExpenses,OperatingIncomeLoss,OtherAccruedLiabilitiesCurrent,OtherAssetsNoncurrent,OtherLiabilitiesNoncurrent,OtherNonoperatingIncomeExpense,OtherPrepaidExpenseCurrent,PaymentsToAcquirePropertyPlantAndEquipment,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PreferredStockSharesIssued,PreferredStockSharesOutstanding,PrepaidExpenseAndOtherAssetsCurrent,PrepaidInsurance,ProceedsFromIssuanceInitialPublicOffering,ProceedsFromIssuanceOfPreferredStockAndPreferenceStock,ProceedsFromStockOptionsExercised,ProfitLoss,PropertyPlantAndEquipmentGross,PropertyPlantAndEquipmentNet,ResearchAndDevelopmentExpense,RestrictedCashAndCashEquivalentsNoncurrent,RetainedEarningsAccumulatedDeficit,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue,StockholdersEquity,StockholdersEquityNoteStockSplitConversionRatio1,StockIssuedDuringPeriodSharesStockOptionsExercised,StockIssuedDuringPeriodValueConversionOfConvertibleSecurities,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueStockOptionsExercised,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,CurrentStateAndLocalTaxExpenseBenefit,DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction,DeferredIncomeTaxExpenseBenefit,DeferredIncomeTaxLiabilities,DeferredTaxAssetsGross,DeferredTaxAssetsNet,DeferredTaxAssetsOperatingLossCarryforwards,DeferredTaxAssetsTaxCreditCarryforwards,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost,DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities,DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent,DeferredTaxAssetsValuationAllowance,DeferredTaxLiabilitiesPrepaidExpenses,DeferredTaxLiabilitiesPropertyPlantAndEquipment,DefinedContributionPlanEmployerDiscretionaryContributionAmount,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost,EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent,EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes,EffectiveIncomeTaxRateReconciliationTaxCredits,IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,NumberOfOperatingSegments,UnrecognizedTaxBenefits,UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense,UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions,ValuationAllowancesAndReservesBalance,ValuationAllowancesAndReservesChargedToCostAndExpense
2021-06-30,2021-08-09,10-Q,"Cyteir Therapeutics, Inc.",CYT,CIK0001662244,USD,3932000.0,3512000.0,760000.0,889000.0,262355000.0,772000.0,772000.0,202053000.0,200305000.0,,198637000.0,198893000.0,,8478975.0,0.001,320000000.0,34474323.0,34104882.0,34000.0,,0.0,334000.0,100000.0,-4.83,0.0,0.0,2422000.0,,,,,,,1721000.0,735000.0,,,627000.0,359000.0,8198000.0,202053000.0,7444000.0,,,,-11295000.0,13000.0,11308000.0,-11308000.0,808000.0,256000.0,420000.0,13000.0,323000.0,,0.001,40000000.0,0.0,0.0,1668000.0,,,,,,2381000.0,1492000.0,8886000.0,256000.0,-68534000.0,,,2619744.0,4.88,4230000.0,,,,700000.0,9.36,193855000.0,,,137066000.0,121627000.0,40000.0,2337947.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2021-09-30,2021-11-12,10-Q,"Cyteir Therapeutics, Inc.",CYT,CIK0001662244,USD,4254000.0,3276000.0,1207000.0,1014000.0,278045000.0,1072000.0,1072000.0,206109000.0,204219000.0,,199822000.0,200078000.0,,8471643.0,0.001,320000000.0,35373374.0,35105537.0,35000.0,,0.0,428000.0,100000.0,-0.33,0.0,0.0,3547000.0,,,,,,,3906000.0,924000.0,932000.0,906000.0,938000.0,206000.0,8267000.0,206109000.0,7530000.0,,,,-11704000.0,48000.0,11752000.0,-11752000.0,895000.0,256000.0,309000.0,48000.0,385000.0,,0.001,40000000.0,0.0,0.0,4397000.0,2227000.0,,,,,2648000.0,1634000.0,8205000.0,256000.0,-80238000.0,,,2714532.0,5.56,5606000.0,,,,600000.0,15.05,197842000.0,,,,14494000.0,15000.0,35062900.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2021-12-31,2022-03-16,10-K,"Cyteir Therapeutics, Inc.",CYT,CIK0001662244,USD,5726000.0,1785000.0,1660000.0,1154000.0,279310000.0,3465000.0,3465000.0,195388000.0,193077000.0,58000.0,189723000.0,189979000.0,178785000.0,8449523.0,0.001,280000000.0,35389453.0,35219834.0,35000.0,137066000.0,0.0,384000.0,479000.0,-2.16,0.0,0.0,11300000.0,38000.0,4278000.0,-68000.0,2000.0,-61000.0,2161000.0,3600000.0,899000.0,907000.0,881000.0,913000.0,,8096000.0,195388000.0,7511000.0,216006000.0,-1189000.0,-36032000.0,-42126000.0,133000.0,42259000.0,-42259000.0,618000.0,256000.0,201000.0,133000.0,370000.0,1189000.0,0.001,40000000.0,0.0,0.0,3354000.0,1397000.0,136120000.0,79655000.0,231000.0,-42126000.0,3209000.0,2055000.0,30959000.0,256000.0,-92053000.0,69892.0,1650548.0,2778963.0,5.8,4149000.0,2.48,1.91,9.02,2100000.0,6.87,187292000.0,,94714.0,137066000.0,136120000.0,231000.0,19499292.0,0.0,,0.0,869000.0,28282000.0,869000.0,24239000.0,3163000.0,402000.0,454000.0,24000.0,27413000.0,396000.0,433000.0,0.0,0.21,-0.295,-0.004,-0.004,0.068,0.025,-42129000.0,-42129000.0,1.0,582000.0,0.0,267000.0,27413000.0,12430000.0
